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Abstract
Background:  The lipoprotein lipase (LPL) hydrolyses circulating triacylglycerol-rich lipoproteins.
Thereby, LPL acts as a metabolic gate-keeper for fatty acids partitioning between adipose tissue for storage
and skeletal muscle primarily for energy use. Transgenic mice that markedly over-express LPL exclusively
in muscle, show increases not only in LPL activity, but also in oxidative enzyme activities and in number of
mitochondria, together with an impaired glucose tolerance. However, the role of LPL in intracellular
nutrient pathways remains uncertain. To examine differences in muscle nutrient uptake and fatty acid
oxidative pattern, transgenic rabbits harboring a DNA fragment of the human LPL gene (hLPL) and their
wild-type littermates were compared for two muscles of different metabolic type, and for perirenal fat.
Results: Analyses of skeletal muscles and adipose tissue showed the expression of the hLPL DNA
fragment in tissues of the hLPL group only. Unexpectedly, the activity level of LPL in both tissues was
similar in the two groups. Nevertheless, mitochondrial fatty acid oxidation rate, measured ex vivo using [1-
14C]oleate as substrate, was lower in hLPL rabbits than in wild-type rabbits for the two muscles under
study. Both insulin-sensitive glucose transporter GLUT4 and muscle fatty acid binding protein (H-FABP)
contents were higher in hLPL rabbits than in wild-type littermates for the pure oxidative semimembranosus
proprius muscle, but differences between groups did not reach significance when considering the fast-
twitch glycolytic longissimus muscle. Variations in both glucose uptake potential, intra-cytoplasmic binding
of fatty acids, and lipid oxidation rate observed in hLPL rabbits compared with their wild-type littermates,
were not followed by any modifications in tissue lipid content, body fat, and plasma levels in energy-yielding
metabolites.
Conclusions: Expression of intracellular binding proteins for both fatty acids and glucose, and their
following oxidation rates in skeletal muscles of hLPL rabbits were not fully consistent with the physiology
rules. The modifications observed in muscle metabolic properties might not be directly associated with
any LPL-linked pathways, but resulted likely of transgene random insertion into rabbit organism close to
any regulatory genes. Our findings enlighten the risks for undesirable phenotypic modifications in micro-
injected animals and difficulties of biotechnology in mammals larger than mice.
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Background
The endothelial cell-associated lipoprotein lipase (LPL)
works to break down triacylglycerol-rich dietary fats
absorbed after a meal, thus generating free fatty acids
transported in the blood. Earlier works suggested that LPL
acts as a metabolic gate-keeper for fatty acid partitioning
between adipose tissue for storage and muscle primarily
for energy use [1]. Then, variation of LPL activity among
fat depots as well as ratio of adipose tissue to skeletal mus-
cle LPL activity, have been proposed to be linked to the
development of regional obesity under certain genetic
predisposition [2]. Transgenic mouse lines that highly
over-express LPL exclusively in muscles, further evidence a
role of LPL in the intracellular fate of nutrients into skele-
tal muscles. Indeed, induced mutant mice over-expressing
human LPL (hLPL) exclusively in muscles have, propor-
tional to the level of LPL transgene expression, increases in
LPL activity and free FA concentration in muscle [3], a
higher number of metabolic organelles (mitochondria,
peroxisomes) in muscles [4], and elevated muscle oxida-
tive enzymes activities [3,4]. Thus, a greater use of lipids
for energy production during fasting has been suggested
in transgenic hLPL mice [5]. In agreement with the inverse
relative rates of fatty acid oxidation and glucose utiliza-
tion in muscle first proposed by Randle and coworkers
[6], mice with over-expression of hLPL specifically in mus-
cles show alterations in muscle glucose metabolism, such
as elevated blood glucose levels [7], increased glycogen
stores [3] or glucose-6-phosphate content [5], and(or)
impaired glucose tolerance [5,8]. Finally, as shown in
mice over-expressing a mutant defective hLPL, enhanced
lipoprotein uptake into cells may also occur via pathways
independent of LPL catalytic activity, resulting in a mito-
chondriopathy as well as in muscle glycogen accumula-
tion similar to the pattern observed in mice expressing
active hLPL [9]. However, another point not studied so far
in hLPL transgenic animals is that uptake of nutrients
and(or) intra-myocellular trafficking to target organelles
are facilitated to a great extent by specific transporters
and(or) binding proteins. Convincing data are available
for the involvement of both membrane-associated and
cytoplasmic fatty acid-binding proteins in fatty acid
uptake by skeletal muscles [10,11]. Especially, a permis-
sive action of heart-type fatty acid binding protein (H-
FABP), also known as muscle FABP or FABP3, in deliver-
ing fatty acids to mitochondrial β-oxidation systems has
been shown [12,13]. Facilitated glucose transport across
membranes of muscle cells mediated by GLUT4 is usually
considered as rate-limiting for glucose utilization by skel-
etal muscles in laboratory rodents [14]. However, it
remains to determine whether LPL effects on muscle oxi-
dative pathways involve modifications in the intracellular
binding of nutrients.
Altogether, metabolic studies in muscles of transgenic ani-
mals help to understand the biological links between fatty
acid uptake, intracellular lipid metabolism, and some
metabolic disorders such as diabetes in human beings.
However, most data have been established in mice. Poten-
tial advantages of rabbit compared with mouse as human
disease model [15,16] relate in part to its lipoprotein pro-
file which more closely mimics that of humans. Therefore,
this study aimed to characterize the oxidative phenotype
of two skeletal muscles in transgenic rabbits harboring a
DNA fragment of the human LPL gene. The study revealed
that despite lack of differences in tissue LPL activity when
compared with their wild-type littermates, transgenic
hLPL rabbits displayed modest increases in both H-FABP
and GLUT4 contents in a pure oxidative muscle and sig-
nificant lower mitochondrial fatty acid oxidation rates in
two skeletal muscles differing in their fiber type composi-
tion. This suggested that a random insertion of hLPL DNA
into the rabbit genome resulted into unexpected disrup-
tion of target nutrient pathways.
Results
Tissue LPL level
An amplification product corresponding to hLPL frag-
ment was evidenced in adipose tissue, semimembranosus
proprius and longissimus muscles of hLPL group, proving
the expression of the transgene in tissues of the rabbit
organism. On the contrary, no signal was detected in the
same tissues of wild-type animals (figure 1). Surprisingly,
hLPL rabbits and their wild-type littermates exhibited
Expression of human lipoprotein lipase (hLPL) mRNA in  transgenic rabbits Figure 1
Expression of human lipoprotein lipase (hLPL) 
mRNA in transgenic rabbits. The cDNA obtained by 
reverse transcription (RT) of total RNA extracted from skel-
etal muscles or perirenal fat and primed by random primers 
followed by 35 cycles of PCR with hLPL-specific primers, was 
loaded on 2% agarose gel. Reaction was performed in parallel 
in the absence of reverse transcriptase (RT-), to ensure for 
lack of genomic DNA contamination. Typical RT-PCR results 
are shown for semimembranosus proprius muscle. Lanes 1–4: 
RT-PCR product in hLPL rabbit; Lane 5: RT- in hLPL rabbit; 
Lane 6: 100 bp DNA ladder; Lane 7–10: RT-PCR product in 
wild-type rabbit; Lane 11: RT- in wild-type rabbit. A band at 
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similar LPL activity for adipose tissue and muscles (table
1).
Plasma metabolites and tissue lipids
Plasma concentrations in triglycerides, free fatty acids,
and glucose, were similar in the two genetic groups (table
2). Moreover, there were no differences between the two
groups for lipid contents in muscles and perirenal adipose
tissue (table 3), as well as for fat proportion relative to
body weight (18.8 ± 1.0 g/kg and 20.6 ± 0.9 g/kg in wild-
type and hLPL rabbits, respectively).
Nutrient oxidative pathways
Muscle content in H-FABP (responsible for cytoplasmic
binding of fatty acids in muscle cells), was 30% higher in
semimembranosus proprius samples of hLPL rabbits
compared with wild-type littermates (table 3). The differ-
ence between the two groups (+56%) did not reach signif-
icance level in the longissimus muscle. This was probably
related to a high intra-assay variability, due to the low
expression of H-FABP in low-fat glycolytic muscles. The
content in insulin-sensitive glucose transporter GLUT4
(the first step in glucose utilization by tissues) was 36%
higher (P = 0.07) in hLPL rabbits than in wild-type ani-
mals for semimembranosus proprius muscle, but it did not
vary in other sites under study (table 3). The
mitochondrial oxidation rates of oleate were reduced by
45% and 41% (P < 0.05) in semimembranosus proprius and
longissimus muscles, respectively (figure 2), in hLPL rab-
bits compared with wild-type littermates. By contrast, oxi-
dation rate in peroxisomes did not vary between groups.
Discussion
Despite a clear evidence for expression of the hLPL trans-
gene in the tissues under study in the hLPL rabbits only,
total LPL (human +native) activity in skeletal muscles or
perirenal adipose tissue was similar in hLPL rabbits and in
their wild-type littermates. This situation contrasts with
the moderately enhanced LPL activity in post-heparin
plasma reported in another line of hLPL transgenic rabbits
[17], and with the marked elevation of LPL activity
observed in adipose tissue [18] or skeletal muscle [3,4,7]
of hLPL mice. A preliminary study in the heart of our hLPL
trangenic rabbits and their wild-type littermates using pol-
yclonal [19] and monoclonal [20] antibodies which rec-
ognize different epitopes of the LPL molecule, did not
evidence any significant differences in total LPL protein
content between groups with both antibodies (data not
shown). Furthermore, plasma triglyceride concentration
was currently found similar in hLPL transgenic rabbits
and wild-type animals, which is again in favor to a similar
content in LPL protein among groups rather than to a cat-
alytically defective hLPL enzyme in transgenic rabbits.
Indeed, triglyceridemia is consistently found lower in
transgenic animals over-expressing a catalytic active hLPL
[7,17] and mutant catalytic defective enzyme [9],
although this effect may be less pronounced on some
genetic backgrounds [9]. Then, a possible explanation is
that failure in hLPL mRNA traduction currently resulted in
no hLPL protein, due to lack of regulatory essential ele-
ments in the transgene sequence [21]. A second explana-
Table 1: Lipoprotein lipase activity1 in tissues of wild-type and 
hLPL transgenic rabbits
Tissues Wild-type rabbits hLPL rabbits
Perirenal fat 1305 ± 336 1420 ± 500
SMP muscle 2036 ± 583 1546 ± 397
LL muscle 493 ± 111 396 ± 58
1Activities are presented as mean ± SEM in perirenal fat, 
semimembranosus proprius (SMP) and longissimus (LL) muscles (nmol 
free fatty acids released. min-1 per g of tissue). There were no 
differences among groups (P > 0.10).
Table 2: Plasma triglycerides, free fatty acids and glucose levels1 
in wild-type and hLPL transgenic rabbits
Plasma metabolites Wild-type rabbits hLPL rabbits
Triglycerides 0.69 ± 0.13 0.81 ± 0.14
Free fatty acids 0.41 ± 0.10 0.41 ± 0.11
Glucose 9.21 ± 0.60 8.60 ± 0.27
1Concentrations are presented as mean + SEM (mmol/L). There were 
no differences among groups (P > 0.10).
Table 3: Lipids and intracellular nutrient trafficking1 in perirenal 
fat and skeletal muscles in wild-type and hLPL rabbits
Wild-type rabbits hLPL rabbits
Perirenal fat
Lipids 677 ± 25 691 ± 31
GLUT4 198 ± 18 248 ± 30
Semimembranosus proprius muscle
Lipids 46.5 ± 4.8 42.9 ± 6.5
H-FABP 222 ± 19 *289 ± 20
GLUT4 96.8 ± 14.9 †131.4 ± 8.5
Longissimus muscle
Lipids 13.1 ± 2.3 11.8 ± 1.3
H-FABP 20.4 ± 4.6 32.0 ± 6.0
GLUT4 76.3 ± 11.8 94.4 ± 12.2
1Data are presented as mean + SEM in perirenal fat, semimembranosus 
proprius (SMP) and longissimus (LL) muscles. Abbreviation used: au 
(arbitrary units).
*Difference in heart-fatty acid bind protein content (H-FABP) in hLPL 
rabbits as compared with wild-type littermates (P < 0.05).
†Difference in insulin-sensitive glucose transporter GLUT4 in hLPL 
rabbits as compared with wild-type littermates (P < 0.10).Lipids in Health and Disease 2004, 3:27 http://www.lipidworld.com/content/3/1/27
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tion may be that expression of hLPL in transgenic animals
led to a down regulation of native LPL.
Surprisingly, despite the lack of difference in LPL activity,
many metabolic differences were found between hLPL
rabbits and their wild-type littermates in semimembranosus
proprius (a muscle composed exclusively of slow-twitch
type I fibers), and to a lesser extent in the fast-twitch gly-
coytic longissimus muscle. However, unlike results in mice,
our findings reported a lower muscle fatty acid oxidation
rates in hLPL rabbits. Others have observed that over-
expression of hLPL gene specifically in skeletal muscle of
transgenic mice rather led to a dose-dependent increase in
oxidative enzymes and to a proliferation of the oxidative
specialized organelles [3,4].
According to the well-known fatty acid-glucose cycle in
skeletal muscles [6], decreased fat oxidation is generally
associated with increased glucose utilization. In accord-
ance with this rule, the muscle content in insulin-sensitive
glucose transporter GLUT4, i.e., the first step of glucose
utilization in skeletal muscle [14], was currently found
higher in the pure oxidative muscle of hLPL rabbits com-
pared with their wild-type littermates. However, possibly
enhanced utilization of glucose was not followed by any
variations in blood glucose level. Either elevated blood
level [7] or similar plasma concentration in glucose [3]
have been observed in hLPL mice compared with wild-
type animals.
Finally, the reason for a higher content of intra-cytoplas-
mic fatty acid binding proteins (H-FABP) in semimembran-
osus proprius muscle of our hLPL rabbits compared with
wild-type animals remains largely unknown. Indeed, a
preferential involvement of H-FABP in delivering intracel-
lular fatty acids to sites of oxidation has been widely sug-
gested [22]. Here, fatty acid oxidation rate was decreased
in hLPL rabbits compared with wild-type littermates, but
muscle lipid content and body fat did not vary among
groups. One hypothesis may be that fatty acids bound to
H-FABP within cell cytoplasm would by-pass any muscle
metabolic pathways. If true, fatty acids would be immedi-
ately re-exported into the blood circulation and subse-
quently oxidized in the liver, presumably to prevent
muscle from toxicity due to increased fatty acids entry. In
vitro and ex vivo findings indeed recently suggest that non-
adipose tissue, such as cardiomyocytes, can re-export fatty
acids when influx exceeds oxidation rate [23]. However,
there is no clear evidence for such a mechanism in our
hLPL rabbits, since plasma concentration of free fatty
acids was found similar in the two genetic groups. Various
results are reported in the literature data on free fatty acids
concentration in serum of hLPL transgenic mammals,
with either similar, increased, or decreased levels [3,4]
depending of mice strain and level of hLPL over-expres-
sion.
Altogether, the various metabolic disruptions in skeletal
muscles of hLPL rabbits are in favor to a random integra-
tion of the micro-injected hLPL DNA within or close to
endogenous genes. In transgenic mice, estimates of the
frequency of these insertional mutations range from 7 to
20% [24]. This may have resulted in a loss of function of
neighboring genes, aberrant expression patterns, and
therefore in unexpected phenotypes. However, genes
coding for LPL, H-FABP, GLUT4, and oxidative pathway
(e.g. carnitine palmitoyl-transferase I) are not clustered on
the same chromosome in the human genome [25] and
likely, although not available, in the rabbit map. There-
fore, if any, the integration site of the foreign DNA must
have conflicted with regulatory elements of any molecular
factors able to modify whole nutrient metabolic cascade.
Conclusions
During the last 15 years, transgenesis has been extended
from mice to larger mammals, with the aim of benefiting
Mitochondrial and peroxisomal oxidation rates of oleate Figure 2
Mitochondrial and peroxisomal oxidation rates of 
oleate. Oxidation rates were measured in freshly excised 
samples of semimembranosus proprius and longissimus muscles, 
using [1-14C]oleate as substrate in the presence (peroxisomal 
oxidation) or absence (total oxidation) of mitochondrial 
inhibitors. Mitochondrial oxidation rates were calculated by 
difference between total and peroxisomal oxidation rates. 
Values shown are mean ± SEM of oleate oxidation (nmole/
min-1 per g of muscle wet weight). The * indicates a significant 
difference (P < 0.05) in mitochondrial oxidation rate in hLPL 
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human health. Transgenic rabbits for LPL gene may offer
useful models to test the relationships between uptake of
nutrients, intracellular trafficking and subsequent
metabolic fate in a species sharing a lipoprotein profile
closely similar to that in Human. However, we currently
reported alterations of nutrient bindings and oxidative
metabolism in skeletal muscles of hLPL rabbits, despite
the lack of difference in tissue LPL activity between trans-
genic rabbits and their wild-type littermates. It is thus sug-
gested that hLPL phenotype emerged from insertional
mutation of hLPL DNA within or close to endogenous
genes. This study underlined the risk of unpredictable
phenotypic properties in micro-injected transgenic rab-
bits, and thereby the difficulty of animal biotechnology in
mammals larger than mice. Nevertheless, transgenic rab-
bits remain useful tools for understanding the relative
importance of the various metabolic pathways involved in
the control of tissue lipid content, especially when the




The Genetic Committee of the French Ministry of Agricul-
ture approved the experiment. Rabbits were reared and
killed in accordance with the French regulations for
humane care and use of animals in research. New-Zealand
White rabbit does were super-ovulated by injections of
porcine-follicle-stimulating hormone, as previously
described [26], and were mated to males of the same
genetic background. Embryos were collected 17 hours
later. The human LPL (hLPL) fragment of genomic DNA,
inserted into a 90-kilobase P1 phagemid together with
regulatory elements, was kindly provided by N. Duverger
(Aventis, Evry, France). The expression of hLPL fragment
in the host organism was governed by the P1 phagemid
promoter. DNA solution was injected into the male pro-
nuclei, and the injected embryos were transferred to the
pseudo-pregnant females (INRA, Laboratoire de Biologie
Cellulaire, Jouy-en-Josas, France). Genomic DNA was
extracted from ear biopsy in the offspring [27]. Presence
or absence of hLPL DNA was screened by PCR using 5'-
CCCTTTTTCCTGTCTTTTT-3' as sense and 5'-AGTGCTT-
GAGACTGTC-TCCTAA-3' as anti-sense primers. These
primers framed a fragment of 201 bp of the human LPL
gene spanning intron 9 and exon 10.
Two transgenic littermate male founders were cross-bred
with 20 females of a standard New-Zealand White line (A-
1067, INRA, France) at the INRA experimental unit (Le
Magneraud, Surgères, France), to provide F1 animals for
analysis. Pup genotypes were determined at the hLPL
locus by PCR from tail tip DNA at the age of 4 weeks,
using the primers described above. Control PCR amplifi-
cation of the actin gene was performed in parallel to
ensure DNA quality.
After weaning (5 weeks), young rabbits were housed col-
lectively by genotype (8 animals per cage), under a con-
trolled light/dark cycle (16/8 h). They were offered free
access to water and to a standard rabbit pelleted diet
(16.5% crude protein, 16.4% cellulose, 2.8% fat, 8.3%
ash, and 3790 kcal/kg gross energy). At 10 weeks of age,
pairs of hLPL rabbits and wild-type littermates of similar
body weight (2400 g ± 53, n = 6 in each genotype) were
selected within litters, and bled in the fed state.
Analysis of plasma metabolites
Enzymatic methods adapted to a Cobas Mira multi-ana-
lyzer apparatus (ABX, Montpellier, France), were used to
determine levels of triglycerides (kit PAP 150, BioMérieux,
Marcy l'Etoile, France), free fatty acids (kit Wako NEFA-C
kit, Richmond, VA, USA) and glucose (kit PAP 1200,
BioMérieux, Marcy l'Etoile, France) in rabbit plasma col-
lected at the time of the death.
Tissue preparation
Portions of perirenal fat, semimembranosus proprius (SMP)
as a muscle composed solely of slow-twitch oxidative fib-
ers, and longissimus  (LL) muscle representing predomi-
nantly fast-twitch glycolytic fibers, were stored at -70°C
until RNA analysis and biochemical measurements.
About 300 mg of each muscle was homogenized immedi-
ately after sacrifice in an appropriated buffer for measure-
ments of ex vivo oxidation rates, as described previously
[28,29].
RNA analysis for expression of the transgene
Total RNA from 600 mg of tissues was extracted by acid
guanidium thiocyanate-phenol chloroform method [30],
and was reverse transcribed into cDNA using pd(N)6 ran-
dom primers (Amersham Biosciences, Orsay, France).
Nested PCR (Quiagen, Courtaboeuf, France) was carried
out (35 cycles) using hLPL cDNA specific primers, as fol-
lows. 5'-TTCTGTGAAGAATGAAGTGG-3' as sense and 5'-
AGTGCTTGACA-CTGTCTCCTAA-3' as anti-sense primers
framed a 137 bp fragment in the exon 10 of hLPL gene.
PCR products were loaded on 2% agarose gel. The ampli-
fied fragment was picked up and sequenced (ESGS Cyber-
gene, Evry, France). In each sample, the absence of
genomic DNA contamination was checked by performing
RT-PCR reaction without reverse transcriptase.
Lipoprotein lipase activity
Lipoprotein lipase (LPL) activity was assessed after
homogenization of the tissues in a buffer composed of
ammonia-HCl (25 mM) pH 8.2, containing EDTA (5
mM), Triton-X-100 (8 g/l), sodium dodecyl sulfate (0.10
g/l), heparin (5000 IU/l) and peptidase inhibitors. Insol-Lipids in Health and Disease 2004, 3:27 http://www.lipidworld.com/content/3/1/27
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uble material was discarded by centrifugation at 20000 ×
g for 20 min at 4°C. As previously described [31], rat
serum was used as activator, and Intralipid® (Pharmacia,
Stockholm, Sweden), into which [3H] triolein has been
incorporated, was used as the substrate. Liberated [3H]-
free fatty acids were quantified by liquid scintillation.
Biochemical analyses
Tissue lipid content was determined after chloroform/
methanol extraction [32]. Muscle content in H-FABP was
determined by ELISA analysis on cytosolic protein prepa-
rations [33] using a rat polyclonal antibody [34]. Taken
into account yields of proteins in cytosolic fractions,
results were converted into arbitrary densitometric (DO)
units per g tissue wet weight. Insulin-sensitive glucose
transporter GLUT4 content was investigated by Western-
blot analysis [35] using a polyclonal antibody raised
against a synthetic peptide of the C-terminal part of
GLUT4, on tissue preparations obtained for LPL activity
determination. Results were converted into arbitrary den-
sitometric (DO) per g tissue wet weight, after taking into
account yields of proteins in tissue preparations.
Rates of fatty acid oxidation
Oxidation rate of oleic acid was determined in freshly
excised muscles as described earlier for rat and bovine
muscles [28], with minor modifications to take into
account rabbit specificity [29]. Briefly, samples were
minced with scissors and homogenized at a tissue concen-
tration of 60 mg/mL in 0.25 M sucrose, 2 mM EDTA, and
10 mM Tris-HCl ice-cold buffer (pH = 7.4), using a glass-
glass homogenizer. A tracer amount of [1-14C]oleic acid
bound to defatted albumin in a 5:1 molar ratio was used
as substrate. Oleate oxidation was measured using L-car-
nitine and other cofactors, in the absence (total oxidation
rate) or presence (peroxisomal oxidation) of mitochon-
drial inhibitors of the respiratory chain (i.e., 75.6 µM
antimycin A, and 10 µM rotenone, SIGMA, St-Louis, MO).
The difference between total oxidation and peroxisomal
oxidation was considered to be mitochondrial oxidation.
All assays were performed in triplicates.
Statistics
The Kruskal-Wallis non-parametric test was used to ana-
lyze differences between groups (SAS Inst, Cary NC, NY,
USA). All data are presented as mean ± SEM.
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